High expression of Foxp3, IL-23p19 and survivin mRNA in colorectal carcinoma

International Journal of Colorectal Disease

Volumn 24, Issue 2, 2009, Pages 151-157

  Stanilov, Noyko ^a   Miteva, Lyuba ^b   Mintchev, Nikolay ^b   Stanilova, Spaska ^b  

^a TRAKIA UNIVERSITY   (Bulgaria)

^b TRAKIA UNIVERSITY   (Bulgaria)

Author keywords

Colorectal carcinoma; Cytokine; IL 12p40; IL 23; qRT PCR

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 23P19; MESSENGER RNA; PROTEIN C JUN; SURVIVIN; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR RELA;

APOPTOSIS; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MALE; MARKER GENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TISSUE LEVEL; UPREGULATION;

COLORECTAL NEOPLASMS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12 SUBUNIT P35; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-23 SUBUNIT P19; INTESTINAL MUCOSA; MICROTUBULE-ASSOCIATED PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 58549095632     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-008-0588-8     Document Type: Article

References (35)

1. Balkwill F, Mantovani A (2001) Inflamation and cancer: Back to virchow? Lancet 357:539-545
2. Coussens LM, Werb Z (2002) Inflamation and cancer. Nature 420:860-867
3. Dunn GP, Old LJ, Schreiber RD (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21:137-148
4. Dranoff G (2004) Cytokines in cancer pathogenesis and cancer therapy. Nature Reviews 4:11-22
5. Bellone G, Smirne C, Mauri F, Tonel E, Carbone A, Buffolino A, Dughera L, Robecchi A, Pirsi M, Emanuelli G (2006) Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implication for survival. Cancer Immunol Immunother 55:684-698
6. Brunda MJ, Luistro L, Hendzak JA, Fountoulakis M, Garotta G, Gately MK (1995) Role of interferon-γ in mediating the antitumor efficacy of interleukin-12. J Immunother Emphas Tumor Immunol 17:71-77
7. Gri G, Chiodoni C, Gallo E, Stoppacciaro A, Liew F, Colombo M (2002) Antitumor effect of Interleukin (IL)-12 in the absence of endogeneous IFN-γ: A role for intrinsic tumor immunogenicity and IL-15. Cancer Research 62:4390-4397
8. Hölscher C (2004) The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases. Med Microbiol Immunol 193:1-17
9. Kawamura K, Bahar R, Natsume W, Sakiyama S, Tagawa M (2002) Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity against tumors. Cancer Gene Therapy 9:109-115
10. Cui G, Goll R, Olsen T, Steigen SE, Husebekk A, Vonen B, Florholmen J (2007) Reduced expression of microenvironmental Th1 cytokines accompanies adenomas-carcinomas sequence of colorectum. Cancer Immunol Immunother 56:985-995
11. O'Hara RJ, Greenman J, MacDonald AW, Gaskell KM, Topping KP, Duthie GS, Kerin MJ, Lee PW, Monson JR (1998) Advansed colorectal cancer is associated with impared interleukin 12 and enhanced interleukin 10 production. Clin Cancer Res 4:1943-1948
12. Dalerba P, Maccalli C, Casati C, Castelli C, parmiani G (2003) Immunology and immunotherapy of colorectal cancer. Crit Rev Oncol Hematol 46:33-57
13. Zhang W, Hart J, McLeod H, Pharm D, Wang H (2005) Differential expression of the AP-1 transcription factor family members in human colorectal epithelial and neurondocrine neoplasm. Am J Clin Pathol 124:11-19
14. Young MR, Yang HS, Colburn NH (2003) Promising molecular targets for cancer prevention: AP-1, NF-kB and Pdcd4. Trends Mol Med 9:36-41
15. Ashida R, Tominaga K, Sasaki E, Watanabe T, Fujiwara Y, Oshitani N, Higuchi K, Mitsuyama S, Iwao H, Arakawa T (2005) AP-1 and colorectal cancer. Immunopharmacology 13:113-125
16. Murphy L, Cleveland M, Kulesza P, Magram J, Murphy K (1995) Regulation of interleukin 12 p40 expression through an NF-kB half-site. Mol Cell Biol 15:5258-5267
17. Blackwell S, Christmas J (1997) The role of nuclear factor-kB in cytokine gene regulation. Am J Respir Cell Mol Biol 17:3-9
18. Yagi H, Nomura T, Nakamura K, Yamazaki S, Kitawaki T, Hori S et al (2004) Crucial role of foxp3 in the development and function of human CD25 +CD4 + regulatory T cells. International Immunology 16:1643-1656
19. Zheng Y, Rudensky A (2007) Foxp3 in control of the regulatory T cell lineage. Nature Immunology 8:457-462
20. Jarnicki A, Lysaght J, Todryk S, Mills K (2006) Suppression of antitumor immunity by IL-10 and TGF-β-producing T cells infiltrating the growing tumor: Influence of tumor environment on the induction of CD4 + and CD8 + regulatory T cells. J Immunol 177:896-904
21. Andersen MH, Svane IM, Becker JC, Straten PT (2007) The universal character of the tumor-associated antigen survivin. Clin Cancer Res 13:5991-5994
22. Baier PK, Wolff-Vorbeck G, Eggstein S, Baumgartner U, Hopt UT (2005) Cytokine expression in colon carcinoma. Anticancer Research 25:2135-2140
23. Dobreva Z, Stanilova S, Miteva L (2008) Differences in the inducible gene expression and protein production of IL-12p40, IL-12p70 and IL-23: involvement of p38 and JNK kinase pathways. Cytokine 43:76-82
24. Endo T, Abe S, Seidlar HB, Nagaoka S, Takemura T, Utsuyama M, Kitagawa M, Hirokawa K (2004) Expression of IAP family proteins in colon cancers from patients with different age groups. Cancer Immunol Immunother 53:770-776
25. Wang YQ, Ugai S, Shimozato O, Yu L, Kawamura K, Yamamoto H, Yamaguchi T, Saisho H, Tagawa M (2003) Induction of systemic immunity by expression of interleukin-23 in murine colon carcinoma cells. Int J Cancer 105:820-824
26. Lo CH, Lee SC, Wu PY, Pan WY, Su J, Cheng CW, Roffler SR, Chiang BL, Lee CN, Wu CW, Tao MH (2003) Antitumor and antimetastatic activity of IL-23. J Immunol 171:600-607
27. Shan B, Hao J, Li Q, Tagawa M (2006) Antitumor activity and immune enhancement of murine interleukin-23 expressed in murine colon carcinoma cells. Cell Mol Immunol 3:47-52
28. Langowski JL, Zhang X, Wu L, Mattson JD, Chen T, Smith K, Basham B, McClanaham T, Kastelein R, Oft M (2006) IL-23 promotes tumor incidence and growth. Nature 442:461-465
29. Ling P, Gately MK, Gubler U, Stern AS, Lin P, Hollfelder K, Su C, Pan YC, Hakimi J (1995) Human IL-12p40 homodimer binds to the Il-12 receptor but does not mediate biologic activity. J Immunol 154:116-127
30. Wang Z, Sato H, Kusam S, Sehra S, Toney L, Dent A (2005) Regulation of IL-10 gene expression in Th2 cells by Jun proteins. J Immunol 174:2098-2105
31. Aggarwal BB (2004) Nuclear factor-kappaB: The enemy within. Cancer Cell 6:203-208
32. Yu LL, Yu HG, Yu JP, Luo HS, Xu XM, Li JH (2004) Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human colorectal carcinoma tissue. World J Gastroenterol 10:3255-3260
33. Le Gouvello S, Bastuji-Garin S, Aloulou N, Mansour H, Chaumette T, Berrehar F, Seikour A, Charachon A, Karoui M, Leroy K, Farcet J-P, Sobhani I (2008) High prevalence of Foxp3 and IL-17 in MMR-proficient colorectal carcinomas. Gut 57:772-779
34. Karanikas V, Speletes M, Zamanakou M, Kalala F, Loules G, Karenidi T, barda A, Gourgoulianis K, Germenis A (2008) Foxp3 expression in human cancer cells. J Transl Med 6:19-30
35. Ebert LM, Tan BS, Browning J, Svobodova S, Russell SE, Kirkpatrick N, Gedye C, Moss D, Ng SP, MacGregor D, Davis ID, Cebon J, Chen W (2008) The regulatory T-cell-associated transcription factor FoxP3 is expressed by tumor cells. Cancer Res 68:3001-3009